High doses intravenous immunoglobulin versus oral cyclosporine in the treatment of severe atopic dermatitis

Iranian Journal of Allergy, Asthma and Immunology

Volumn 4, Issue 3, 2005, Pages 139-143

  Bemanian, Mohammad Hassan ^a   Movahedi, Masoud ^a   Farhoudi, Abolhassan ^a   Gharagozlou, Mohammad ^a   Seraj, Mehran Heidari ^a   Pourpak, Zahra ^a   Nabavi, Mohammad ^a   Aghamohammadi, Asghar ^a   Shirkhoda, Zahra ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Atopic dermatitis; Cyclosporine; Intravenous immunoglobulin; Treatment

Indexed keywords

CYCLOSPORIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN E;

ARTICLE; ATOPIC DERMATITIS; CHILD; CHILL; CLINICAL ARTICLE; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; EGG; EOSINOPHIL COUNT; FEMALE; FEVER; FUNCTION TEST KIT; HERPETIC KERATOCONJUNCTIVITIS; HIRSUTISM; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; KERATOCONJUNCTIVITIS; MALE; MILK; MITE; PRICK TEST; RADIOALLERGOSORBENT TEST; SCORING ATOPIC DERMATITIS; SEVERE ATOPIC DERMATITIS; SINGLE DRUG DOSE; SKIN DISEASE ASSESSMENT; SKIN TEST;

EID: 55449114921     PISSN: 17351502     EISSN: 17355249     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Kay J, Gawkrodger DJ, Mortimer MJ, Jaron AG. The prevalence of childhood atopic eczema in a general population. J Am Acad Dermatol 1994; 30(1):35-9.
2. Boguniewicz M, Eichenfield LF, Hultsch T. Current management of atopic dermatitis and interruption of the atopic march. J Allergy Clin Immunol 2003; 112(6 Suppl):140-50.
3. Bunikowski R, Staab D, Kussebi F, Brautigam M, Weidinger G, Renz H, et al. Low-dose cyclosporin A microemulsion in children with severe atopic dermatitis: clinical and immunological effects. Pediatr Allergy Immunol 2001; 12(4):216-23.
4. Boguniewicz M, Leung DYM: Atopic dermatitis. In: Middleton's Allergy principles and practice. USA: Mosby, Elsevier, 2003: 1559-75.
5. Paul C, Lahfa M, Bachelez H, Chevret S, Dubertret L. A randomized controlled evaluator-blinded trial of intravenous immunoglobulin in adults with severe atopic dermatitis. Br J Dermatol 2002; 147(3):518-22.
6. Williams HC, Burney PG, Hay RJ, Archer CB, Shipley MJ, Hunter JJ, et al. The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. I. Derivation of a minimum set of discriminators for atopic dermatitis. Br J Dermatol 1994; 131(3):383-96.
7. E. Ann Bingham, Guidelines to management of atopic dermatitis John Harper, Arnold orange, and Neil prose In: Text book of pediatric dermatolog. U.K Blackwell Science 2000: 215-30.
8. Sidbury R, Hanifin JM. Systemic therapy of atopic dermatitis. Clin Exp Dermatol 2000; 25(7):239-66.
9. Novak N, Bieber T, Leung DY. Immune mechanisms leading to atopic dermatitis. J Allergy Clin Immunol 2003; 112(6 Suppl):128-39.
10. Tan BB, Weald D, Strickland I, Friedmann PS. Doubleblind controlled trial of effect of housedust-mite allergen avoidance on atopic dermatitis. Lancet 1996; 347(8993):15-8.
11. Berth-Jones J, Finlay AY, Zaki I, Tan B, Goodyear H, Lewis-Jones S, et al. Cyclosporine in severe childhood atopic dermatitis: a multicenter study. J Am Acad Dermatol 1996; 34(6):1016-21.
12. Zonneveld IM, De Rie MA, Beljaards RC, Van Der Rhee HJ, Wuite J, Zeegelaar J, et al. The long-term safety and efficacy of cyclosporin in severe refractory atopic dermatitis: a comparison of two dosage regimens. Br J Dermatol 1996; 135(Suppl 48):15-20.
13. Wakim M, Alazard M, Yajima A, Speights D, Saxon A, Stiehm ER. High dose intravenous immunoglobulin in atopic dermatitis and hyper-IgE syndrome. Ann Allergy Asthma Immunol 1998; 81(2):153-8.
14. Jolles S, Sewell C, Webster D, Ryan A, Heelan B, Waite A, et al. Adjunctive high-dose intravenous immunoglobulin treatment for resistant atopic dermatitis: efficacy and effects on intracellular cytokine levels and CD4 counts. Acta Derm Venereol 2003; 83(6):433-7.